$AFCG

TANNENBAUM LEONARD M purchased $119K of AFCG

TANNENBAUM LEONARD M purchased 34,606 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.43 ($3.41–$3.46, $0.12M total) across 2 trades over 2026-08-26 to 2026-08-27.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Aug 28, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AFCG
Neutral
medium confidence
Mentioned
$AFCG
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The purchase adds ~0.5% to the director's existing stake, unlikely to affect market perception.

02

Market read

A modest insider purchase with limited market impact.

03

What to watch

The director already holds a large stake; the incremental purchase may not reflect new information about the business.

Relevance 5/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider trades; directors often buy to maintain ownership levels.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

Director Leonard Tannenbaum purchased 34,606 shares of Advanced Flower Capital for $118.8K, increasing his stake to over 6.7M shares.

Expected impact

Minor upward pressure, unlikely to move price materially.

Evidence & confidence

A $119K purchase by a 10% owner is a small fraction of total holdings and typical for a 10b5-1 plan, offering limited trading edge.

Market effects

None significant; the transaction is company‑specific.

No broader regional effect.

Minimal.

Counterpoint

Insider purchase could be routine portfolio rebalancing, not a bullish signal.

Key entities

  • Advanced Flower Capital Inc.

    Cannabis‑focused investment firm.

  • Leonard Tannenbaum

    Director and 10% owner of AFCG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.